Huili Li and his laboratory had demonstrated that inhibition of GSK‐3β could suppress the proliferation of colorectal cells by the downregulation of activity of NF‐κB and NF‐κB‐mediated target genes transcription, which may be of benefit for clinical outcome in patients suffering from colon cancer in future 8. The gene discussed is NFKB1; the disease is malignant colon neoplasm.